To include your compound in the COVID-19 Resource Center, submit it here.

FDA to issue multiple biosimilars guidances

FDA plans to issue multiple guidance documents on biosimilars, including one to be released "by the end of the year,"

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE